Recently, King Charles III of the United Kingdom visited the Melanoma Institute Australia (MIA). The institute’s co-directors, Professor Georgina Long AO and Professor Richard Scolyer AO, along with Associate Professor Linda Martin, discussed with King Charles III the institute’s significant ongoing work in the prevention and understanding of skin cancer. MIA is one of 16 Australian sites involved in the Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) initiative – the world’s largest melanoma cohort study. As part of this study, Canfield Scientific’s VECTRA® WB360 whole-body imaging system is utilized to enhance screening examinations and revolutionize research in Australia, which has one of the highest rates of skin cancer globally.
In The Media News
A recent article on Techzine highlights the growing importance of advanced total body technology in areas with rising skin cancer rates and increased staff shortages in healthcare. Showcasing Canfield Scientific’s VECTRA® WB360, the article shares how the innovative whole-body 3D imaging system is being utilized for enhancing screening examinations and revolutionizing research. With a growing presence in Europe and worldwide, VECTRA WB360 has become synonymous with medical innovation in the field of dermatology. By streamlining lesion surveillance and reducing the workload of both dermatologists and researchers, the system is a particularly valuable asset in regions that are facing rising skin cancer rates and increasing staff shortages in healthcare.
The Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) has been honored with the Aspire Scholarship Eureka Award for Interdisciplinary Scientific Research. This achievement recognizes the collaborative team effort behind the world’s largest melanoma cohort study, which focuses on investigating “the effectiveness of 3D total body photography to assist clinicians, streamline skin cancer imaging and enhance diagnosis.”1
In a recent podcast with Health University of Utah, Doug Grossman, MD, PhD, Head of the Mole Mapping Program at the Melanoma Center at Huntsman Cancer Institute, emphasized the important role that total body photography and mole mapping have in assisting dermatologists in early detection of skin cancer.
Australian TV program Sunrise Morning Show featured Canfield Scientific's HairMetrix® software, the first AI-driven non-invasive hair analysis tool, in action at Hair Doctors, a leading hair restoration clinic in Sydney, Australia. HairMetrix allows doctors to effortlessly capture high-quality images of the hair, to deliver fully automated analysis results to patients immediately, and to provide objective outcome tracking without the need for hair clipping.
The Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) recently launched a new location with Pinnacle Dermatology, a specialized dermatology practice group in Orange, Australia. This marks ACEMID’s fourth regional site in New South Wales and its 14th in the country. As part of the world’s largest melanoma cohort study, Canfield’s VECTRA® WB360 whole-body imaging system will be utilized to further bolster dermatologic research in Australia, which has one of the highest skin cancer rates globally.
NBC News featured Canfield Scientific's trailblazing VECTRA WB360 whole-body imaging system in action at Memorial Sloan Kettering Cancer Center (MSKCC) on Long Island. This innovative system employs both cross-polarized and non-polarized lighting to generate incredibly detailed 3D images of the entire body in a single capture. Powered by Canfield's state-of-the-art DermaGraphix® software, these images are pivotal in the surveillance of pigmented lesions and rashes.
The CBS News Eye on Health recently highlighted Canfield's groundbreaking VECTRA WB360 whole-body imaging system, now in use at Allegheny Health Network (AHN) Cancer Institute in Pittsburgh, PA. This innovative system, equipped with 46 stereo vision pods utilizing cross-polarized and non-polarized lighting, produces highly detailed 3D images of the entire body in a single scan. Powered by Canfield's advanced DermaGraphix® software, these images play a vital role in the surveillance of pigmented lesions and rashes.
Dr. Robyn Siperstein, MD, shares her experience with Canfield Scientific’s revolutionary Artificial Intelligence (AI) and Augmented Reality (AR) technology with MedEsthetics Magazine. She states: “With more than 15 years of experience as a practitioner in this field, I've been thrilled to witness how these cutting-edge tools are empowering providers and revolutionizing the patient experience.” Dr. Siperstein and her staff at the Siperstein Dermatology Group in South Florida seamlessly integrate AI and AR technology in patient consultations. Dr. Siperstein explains how she leverages the 2D and 3D imaging analysis and simulations of Canfield’s VISIA® and VECTRA® 3D to create options for highly customized treatments, ensure superior outcomes, and actively engage patients in their care journey. AI is also utilized in their hair transplant consultations with HairMetrix®– the first AI-driven, non-invasive hair consultation software pioneered by Canfield Scientific. Its unclipped insights and immediate in-depth analysis enable swift, precise decisions, especially for urgent cases or patients reluctant to sacrifice thinning hair for analysis.
Canfield’s VECTRA WB360 was recently installed at Allegheny Health Network Cancer Institute at West Penn Hospital. As the first of its kind available in western Pennsylvania, the whole-body imaging system will be the centerpiece of the hospital’s newest facility. Their patients will be provided with one-stop access to the technology, therapies, and expertise they would need on their journey to health. The VECTRA WB360 captures patient images using 46 stereo vision pods with cross-polarized and non-polarized lighting, generating a single 3D image of the entire body. Incorporating Canfield’s DermaGraphix® software, the 3D images are used for pigmented lesion and rash surveillance. The surgical oncologist and director at AHN Skin Cancer commented on the importance of high-quality imaging: “Having better images means better care for our patients, and more timely detection of suspicious abnormalities”. This system and software will allow him and his staff to offer better care aimed at prevention as well as conduct clinical and translational research that will focus on early detection.
